OP
HCAR

Omni Partners’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Omni Partners’s Portfolio HCAR Stock Details HCAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$5.67M Buy
+585,573
New +$5.87M 0.28% 36

Other funds holding HCAR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

Omni Partners's HCAR Position: Q1 2021 in Review

Omni Partners opened a new position in Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q1 2021: 585,573 shares worth $5.67M. The stake represents 0.28% of the portfolio and ranks #36 among its holdings.

58 funds tracked by Wall St. Rank hold HCAR as of Q1 2021.

  • Omni Partners held 585,573 shares of Healthcare Services Acquisition Corporation Class A Common Stock worth $5.67M as of Q1 2021.
  • Healthcare Services Acquisition Corporation Class A Common Stock was a new Omni Partners position in Q1 2021.
  • Healthcare Services Acquisition Corporation Class A Common Stock made up 0.28% of Omni Partners's portfolio in Q1 2021, its #36 holding.
  • 58 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q1 2021.

Based on Omni Partners's 13F filing for Q1 2021, filed 17 May 2021.